{"id":"W4378364283","doi":"10.1016/j.mad.2023.111825","title":"RETRACTED: A feasibility study of the combination of intranasal insulin with dulaglutide for cognition in older adults with metabolic syndrome at high dementia risk – Study rationale and design","year":2023,"lang":"en","type":"article","venue":"Mechanisms of Ageing and Development","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":4,"is_retracted":true,"has_abstract":false,"ca_institutions":"Hamilton Health Sciences; Population Health Research Institute; McMaster University","funders":"National Institutes of Health; Alzheimer's Association","keywords":"Dementia; Metabolic syndrome; Cognition; Medicine; Insulin; Diabetes mellitus; Dulaglutide; Cognitive decline; Gerontology; Internal medicine; Psychiatry; Endocrinology; Type 2 diabetes; Exenatide; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null}